放射線治療市場レポート：動向、予測、競合分析（～2031年）

世界の放射線治療市場の将来は、前立腺がん、乳がん、肺がん、大腸がん、子宮頸がんの各市場における機会によって有望視されています。世界の放射線治療市場は、2025年から2031年までのCAGRが5.9%で、2031年までに推定113億米ドルに達すると予想されています。この市場の主な促進要因は、がん罹患率の増加、放射線治療技術の進歩、高齢者人口の増加です。

• Lucintelの予測によると、タイプ別では、外部放射線療法が予測期間中最大セグメントであると思われます。これは、がん細胞への直接照射の精度が高いため、正常組織へのダメージが少ない一方で、腫瘍医は治療に高線量の放射線療法を使用できるためです。
• 用途別では、前立腺がんの罹患率が高まっていることと、他のがん種に比べて成功率が高いことから、前立腺がんが引き続き最大セグメントとなると思われます。
• 地域別では、放射線治療に対する意識の高まり、ヘルスケア支出の増加、同地域における高齢者人口の増加により、アジア太平洋が予測期間中に最も高い成長を示すと予想されます。

放射線治療市場の戦略的成長機会

新たな用途や技術が登場し、治療の幅と深みが増すにつれて、放射線治療市場には今後数年間で大きな成長の可能性があります。より的を絞ったアプローチとともに高度な治療を必要とするがんの罹患率の上昇により、さまざまな用途で戦略的な成長機会が生じています。

• 陽子線治療センターの拡大：陽子線治療センターの拡大は、放射線治療業界における魅力的な成長機会です。副作用の少なさや標的精度の高さといった陽子線治療の利点が認知されるにつれて、陽子線治療に対する需要は増加しています。新しい陽子線治療センターは、特に米国のように先進的ながん治療が制限されている国々で、世界中で設立されつつあります。そのため、放射線治療市場の成長は陽子線治療の利用拡大によって牽引され、より多くの人々にとって手頃な価格になり、その受容が促進されると予測されます。
• 個別化治療のためのAI利用の成長：臨床放射線治療計画にAIを活用することへの市場の関心が高まっています。AIは多くの変数を評価することができるため、有効性を最大化し副作用を最小化する個別化治療の作成が可能になります。AIの開発が進めば、放射線治療への応用範囲が広がり、治療効果や患者ケアのさらなる向上が期待されます。この動向は、放射線治療市場の将来において中心的な役割を果たすと思われる、新しいAIベースの製品やソフトウェアの成長に拍車をかけています。
• 低分割放射線治療の拡大：臨床医と患者がより良い、より迅速な治療法を求めているため、低分割放射線治療の利用は拡大し続けています。低分割放射線治療は短期間で治療を行うため、ヘルスケアシステムの負担が軽減され、患者エクスペリエンスも向上します。これは、特に短時間で高線量の放射線を照射するがんの治療に有利です。

低分割放射線治療の導入が進むにつれ、特に多様な健康問題を抱える人々にとって、低コストで煩わしさの少ない治療法であることから、市場の拡大が予想されます。

• 新興市場における放射線治療の拡大：新興市場は放射線治療サービスの成長にとって大きな機会となります。これらの地域ではヘルスケアのインフラが整備され、放射線治療を含む高度ながん治療に対する需要が高まっています。新興市場の政府や民間医療部門は、放射線治療センターの建設や最新技術の導入に多額の投資を行っています。この拡がりは、世界規模でこれまで以上に多くの患者に高度ながん治療を提供することで、放射線治療市場を支えるものと期待されています。こうした新興国市場の発展が続くにつれて、放射線治療市場全体の成長と発展に重要な役割を果たすことになると思われます。

放射線治療市場における戦略的成長機会は、陽子線治療センターの新設、個別化治療における人工知能の統合、低分割放射線治療の拡大、新興経済諸国における成長、がん治療を大幅に改善するための免疫療法との連携によってもたらされています。これらの機会を狙う戦略は、単に放射線治療の範囲を広げるだけでなく、その有効性を高め、患者の転帰を改善しています。このような変化は近い将来に発展すると予想され、個別化されたがん管理療法をより多くの患者に効率的に提供することを目指し、放射線治療市場の成長に影響を与えると思われます。

放射線治療市場の促進要因・課題

放射線治療市場は、技術開発、経済要因、規制の相互作用によって形成されています。これらの側面は技術革新と市場拡大に拍車をかけると同時に、停滞を避けるために対処すべき重大な課題も提示しています。主な促進要因としては、がん患者の増加、放射線治療の技術向上、ヘルスケア費用への支援、放射線治療に対する意識の高まり、政府のがん治療強化プログラムなどが挙げられます。

放射線治療市場の成長を促進する要因は以下の通りです：

• がん罹患率の上昇：がん罹患率の上昇：世界のがん患者の増加は、放射線治療市場の重要な促進要因です。高齢化や生活習慣ががんリスクの一因となっていることから、効果的な治療オプションに対する需要が高まっています。ライフスタイルの変化、人口の高齢化、環境の影響などさまざまな要因によってがん患者が増加するにつれ、放射線治療の必要性が顕著になっています。
• 技術の進歩：陽子線治療、MR-リニアックシステム、AI統合の開発など、放射線技術の急速な進歩は、放射線治療の効果と効率を高めています。これらの技術は、治療をより安全で正確なものにし、より多くの患者にとって利用しやすいものにしています。
• 政府の取り組みと資金援助：各国政府は、がん治療のインフラ整備と放射線治療へのアクセス拡大を目的としたヘルスケアイニシアチブへの投資を増やしています。こうしたイニシアチブは、認知度を高め、利用可能な治療センターを増やすことで市場の成長に大きく寄与しています。
• 患者の意識と受容：がん治療と放射線治療の利点に対する認識が高まるにつれ、より多くの患者が治療を受けるようになっています。このような認識の変化は、市場の需要にプラスの影響を与えています。

放射線治療市場の成長を阻害する課題は以下の通りです：

• 機器と治療費の高騰：高度な放射線治療機器の初期設定には多額の費用がかかるため、一部のヘルスケア施設、特に新興市場では新技術の導入が困難な場合があります。このような高額費用のために、最新の放射線治療オプションへのアクセスが制限される可能性があります。
• 訓練を受けた専門家の不足：有資格の放射線腫瘍医、医学物理士、その他の訓練を受けた人材の不足は、高度な放射線治療技術の効果的な実施を妨げる可能性があります。このギャップは、患者の治療へのアクセスを遅らせ、治療成績に影響を及ぼす可能性があります。
• 規制上の課題：放射線治療業界は、国によって異なる複雑な規制状況を乗り切らなければなりません。厳しい規制への対応は、製品上市の遅れや新技術導入に伴うコスト増につながる可能性があります。
• 患者固有の要因：個々の患者の健康状態や遺伝的素因は治療結果に影響を与える可能性があります。これらの因子を理解することは放射線治療の個別化に不可欠ですが、治療プロトコルの中でこれらの因子に適切に対処することには課題が残っています。

結論として、放射線治療市場はいくつかの成長要因に牽引される一方で、大きな課題にも直面しています。これらの要素のバランスをとることが、この分野を発展させ、患者が最も効果的で利用しやすい治療を受けられるようにするために重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界の放射線治療市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析（2019～2031年）

• マクロ経済動向（2019～2024年）と予測（2025～2031年）
• 世界の放射線治療市場の動向（2019～2024年）と予測（2025～2031年）
• 世界の放射線治療市場：タイプ別
  • 外部放射線治療
  • 内部放射線療法
  • 全身放射線療法
• 世界の放射線治療市場：用途別
  • 前立腺がん
  • 乳がん
  • 肺がん
  • 大腸がん
  • 子宮頸がん
  • その他
• 世界の放射線治療市場：最終用途別
  • 病院
  • 独立放射線治療センター
  • その他

第4章 市場動向と予測分析：地域別（2019～2031年）

• 世界の放射線治療市場：地域別
• 北米の放射線治療市場
• 欧州の放射線治療市場
• アジア太平洋地域の放射線治療市場
• その他地域の放射線治療市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の放射線治療市場の成長機会：タイプ別
  • 世界の放射線治療市場の成長機会：用途別
  • 世界の放射線治療市場の成長機会：最終用途別
  • 世界の放射線治療市場の成長機会：地域別
• 世界の放射線治療市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の放射線治療市場の能力拡大
  • 世界の放射線治療市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

The future of the global radiotherapy market looks promising with opportunities in the prostate cancer, breast cancer, lung cancer, colorectal cancer, and cervical cancer markets. The global radiotherapy market is expected to reach an estimated $11.3 billion by 2031 with a CAGR of 5.9% from 2025 to 2031. The major drivers for this market are the increasing cancer incidence, advancements in radiotherapy technology, and the growing geriatric population.

• Lucintel forecasts that, within the type category, external beam radiation therapy will remain the largest segment over the forecast period due to the accuracy of the direct beams at the cancerous cells, which results in less damage to normal tissues, while allowing oncologists to use higher doses of radiotherapy for treatment.
• Within the application category, prostate cancer will remain the largest segment due to the growing incidence of prostate cancer and higher success rate as compared to other cancer types.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the growing awareness about radiotherapy, rising healthcare expenditure, and increasing geriatric population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Radiotherapy Market

The phenomenon and trends prevailing in the radiotherapy market are changing for the better due to technological advancements, changing healthcare needs, and the search for more efficient ways to treat cancer. New developments in this area, expanding beyond the limited view of seeking only cancer cures, are improving not only the effectiveness of radiotherapy but also reinforcing its use in a greater variety of cancers and for more patients. As healthcare institutions and practitioners remain innovative, it is safe to say that these trends will transform the cancer care sector for the better by providing more treatment options and offering greater hope to patients.

• Proton Therapy Expansion: Proton therapy is emerging as one of the leading approaches in the treatment of specific tumor types, especially those located close to critical organs such as the brain and spinal cord. This trend stems from the fact that high doses of radiation can be delivered within a shorter distance from the tumor while inflicting less or no damage to normal tissue. Several proton therapy facilities are being established globally, thereby increasing the accessibility of advanced treatment to a growing pool of patients. More facilities and manpower are expected to be developed for the administration of proton therapy, further diversifying the radiotherapy industry and improving outcomes.
• Integration of Artificial Intelligence (AI): Artificial intelligence is changing the landscape of the radiotherapy market by increasing the precision and speed of treatment planning and delivery. Complex images are analyzed, the optimal radiation dose is determined, and the outcomes for each patient are predicted as accurately as possible, thanks to specially developed AI algorithms. This approach is also helping to shorten the treatment planning phase, reducing the waiting period for patients before treatment commences. Improvements in AI will enhance integration in radiotherapy, with expectations for greater precision in treatments, fewer adverse effects, and better results for patients.
• Increasing Use of Image-Guided Radiotherapy (IGRT): Recently, there has been a significant advent of new technology in Image-Guided Radiotherapy (IGRT). IGRT includes the availability of live images, such as Computed Tomography (CT) or MRI-guided tumor volume imaging, during radiotherapy delivery. This allows for adjustments during treatment to accommodate tumor movements or patient repositioning. The increasing use of IGRT is enhancing treatment accuracy, lowering unintended radiation doses to patients, and improving the prospects of radiation therapy for more types of cancer.
• Combination of Radiotherapy with Immunotherapy: Integrating radiotherapy with immunotherapy is a new trend that has high potential and will improve outcomes in cancer treatment. Immunotherapy enhances the body's immune response to detect and address cancerous tissues, complementing radiotherapy that involves radiation exposure. This combination treatment strategy is effective for cancers that do not respond to conventional treatment approaches. Research is ongoing, and clinical trials are underway to establish the best combinations and sequences of such treatments to ensure their maximal effect and broaden their clinical applications.

Newly developed concepts within the radiotherapy market, such as management of proton therapy by centers, incorporation of AI, the rise in application of IGRT, combination with immunotherapy, and individualization of treatment, stand to change the narrative around cancer treatment. These improvements are not just augmenting the accuracy and efficacy of radiotherapy techniques; they are also expanding the scope of radiotherapy usage for more patients with various oncological diseases. As these trends advance, they are poised to propel the growth of the radiotherapy market and improve the prognosis for patients diagnosed with cancer worldwide.

Recent Developments in the Radiotherapy Market

The radiotherapy market is inundated with new technologies, approved regulations, and increasing investment interest due to cancer treatments. All these developments aim to enhance the quality of radiotherapy treatments and improve patient outcomes. As the demand for advanced cancer therapies increases, the thermotherapy market is expanding, showcasing advanced techniques and equipment to develop individualized therapies targeting specific ailments.

• Advancement in Proton Therapy: Proton therapy has developed significantly and has emerged as a breakthrough in the radiotherapy market, as it offers better chances of targeting tumor regions without harming healthy tissues. Recently, efforts have focused on making proton therapy more viable and addressing existing limitations in the number of centers offering this therapy due to high costs. These trends encourage the use of proton therapy for many more malignancies, even those currently treated solely with surgical methods or those resistant to conventional radiotherapy. The rise in the availability of proton therapy services is anticipated to have substantial potential in the radiotherapy market by reaching more patients.
• Integration of Artificial Intelligence in Treatment Planning: The use of artificial intelligence (AI) in the planning of radiotherapy treatments is changing the market for the better by increasing the efficiency and accuracy of treatment protocols. Recently, AI is being applied to manage patient information, optimize radiation doses, and predict outcomes. This evolution not only shortens the duration of treatment planning but also facilitates greater individualization in treatment approaches. Continued advancements in AI will further enhance its effectiveness in radiotherapy, contributing to market growth.
• Expansion of Stereotactic Body Radiotherapy (SBRT): Stereotactic Body Radiotherapy (SBRT) is quickly becoming the conventional option for managing specific types of cancer, particularly carcinomas of the lung, liver, and spine. Delivery of SBRT typically occurs in three to five treatment sessions rather than the numerous fractions traditionally offered, resulting in fewer complications compared to surgical approaches. The last decade has focused on improving SBRT modalities, refining patient selection, and broadening its application for additional oncological indications. Given the clinically satisfactory results achieved, the market for these systems is expected to grow as more patients seek effective yet less harmful treatment through SBRT.
• Development of MR-Linac Technology: The advancement of Magnetic Resonance Linear Accelerator (MR-Linac) technology represents a revolutionary advance in radiation oncology. MR-Linac allows for tumor visualization while directing radiation, leveraging the benefits of MRI and the linear accelerator. This technology enhances radiation delivery to the tumor and allows for adjustments based on tumor movement, making treatment more effective and minimizing side effects. The emergence of MR-Linac technology improves the effectiveness of radiotherapy for complex and mobile tumors, thus positively contributing to the growth of the radiotherapy market.

Recent trends in the radiotherapy market, such as the advent of proton therapy, incorporation of artificial intelligence, expansion of SBRT, MR-Linac technology, and hypofractionated radiotherapy, are transforming cancer treatment. These developments are not only increasing the accuracy and efficacy of radiotherapy but also enhancing the affordability and convenience of this treatment.

Strategic Growth Opportunities for Radiotherapy Market

There is substantial growth potential in the radiotherapy market in the coming years as new applications and technologies emerge, enhancing the breadth and depth of therapies. Strategic growth opportunities are arising in different applications due to the rising incidence of cancer requiring advanced treatment alongside more targeted approaches.

• Expansion of Proton Therapy Centers: The expansion of proton therapy centers presents an attractive growth opportunity in the radiotherapy industry. Demand for such therapy is increasing as the advantages of proton therapy, such as lower side effects and higher targeting precision, become more recognized. New proton therapy centers are being established worldwide, especially in countries where advanced cancer treatments are limited, such as in the US. Therefore, it is predicted that the growth of the radiotherapy market will be driven by increased proton therapy usage, making it affordable to a larger population and encouraging its acceptance.
• Growth in the Use of AI for Personalized Treatment: There is growing market interest in utilizing AI for clinical radiation therapy planning. AI can evaluate many variables, allowing for the creation of individualized therapies that maximize efficacy and minimize adverse effects. Continued developments in AI will lead to broader applications in radiotherapy, further improving the effectiveness of procedures and patient care. This trend is fueling the growth of new AI-based products and software that are likely to play a central role in the future of the radiotherapy market.
• Expansion of Hypofractionated Radiotherapy: The use of hypofractionated radiotherapy continues to grow as clinicians and patients seek better and faster treatment methods. Hypofractionation involves delivering treatment over a shorter period, easing the burden on the healthcare system and improving patient experience. This is particularly favorable for treating cancers with shorter, higher radiation doses.

With the increasing adoption of hypofractionated radiotherapy, market expansion is anticipated, as this is a low-cost and less cumbersome treatment option, especially for populations with diverse health concerns.

• Radiotherapy Expansion in Emerging Markets: Emerging markets offer significant opportunities for the growth of radiotherapy services. With improvements in healthcare infrastructure in these regions, the demand for advanced cancer therapies, including radiotherapy, is rising. Governments and private health sectors in emerging markets are investing heavily in building radiotherapy centers and deploying modern technology. This escalation is expected to support the radiotherapy market by providing advanced cancer treatment to more patients than ever before on a global scale. As these markets continue to develop, they are likely to play a vital role in the overall growth and development of the radiotherapy market.

Strategic growth opportunities in the radiotherapy market are being driven by the establishment of new proton therapy centers, the integration of artificial intelligence in personalized treatment, the expansion of hypofractionated radiotherapy, growth in developing economies, and collaboration with immunotherapy to significantly improve cancer treatment. Strategies targeting these opportunities are not just widening the scope of radiotherapy; they are also enhancing its efficacy and improving patient outcomes. These changes are anticipated to develop in the near future and will influence the growth of the radiotherapy market toward delivering personalized cancer management therapies efficiently to more patients.

Radiotherapy Market Driver and Challenges

The radiotherapy market is shaped by the interplay between technological development, economic factors, and regulations. These aspects spur innovation and market expansion while also presenting significant challenges that need to be addressed to avoid stagnation. Key drivers include the rise in cancer cases, technological improvements in radiation therapy, support for healthcare costs, increased awareness of radiotherapy treatments, and government cancer treatment enhancement programs.

The factors responsible for driving the growth of the radiotherapy market are:

• Rising Cancer Incidence: The global increase in cancer cases is a significant driver of the radiotherapy market. With an aging population and lifestyle factors contributing to cancer risk, the demand for effective treatment options is escalating. As cancer cases rise due to various factors like lifestyle changes, population aging, and environmental influences, the need for radiotherapy becomes more pronounced.
• Technological Advancements: Rapid advancements in radiation technology, such as the development of proton therapy, MR-Linac systems, and AI integration, are enhancing the effectiveness and efficiency of radiotherapy. These technologies are making treatments safer, more accurate, and accessible to a broader patient population.
• Government Initiatives and Funding: Governments are increasingly investing in healthcare initiatives aimed at improving cancer treatment infrastructure and expanding access to radiotherapy. These initiatives contribute significantly to market growth by enhancing awareness and increasing the number of available treatment centers.
• Patient Awareness and Acceptance: The growing awareness of cancer treatments and the benefits of radiotherapy is encouraging more patients to seek treatment. This shift in perception is positively influencing market demand.

However, the radiotherapy market faces challenges that may impede growth, including:

• High Costs of Equipment and Treatment: The initial setup costs for advanced radiotherapy equipment are substantial, making it difficult for some healthcare facilities, especially in emerging markets, to adopt new technologies. This high expense can limit access to modern radiotherapy options.
• Shortage of Trained Professionals: A shortage of qualified radiation oncologists, medical physicists, and other trained personnel may hinder the effective implementation of advanced radiotherapy techniques. This gap can delay patient access to treatment and affect outcomes.
• Regulatory Challenges: The radiotherapy industry must navigate complex regulatory landscapes, which can vary by country. Compliance with stringent regulations may lead to delays in product launches and increase the costs associated with new technology adoption.
• Patient-Specific Factors: Individual patient health conditions and genetic predispositions can influence treatment outcomes. Understanding these factors is essential for personalizing radiotherapy, yet challenges remain in adequately addressing them within treatment protocols.

In conclusion, while the radiotherapy market is driven by several growth factors, it also faces significant challenges. Balancing these elements is critical for advancing the field and ensuring patients receive the most effective and accessible treatments possible.

List of Radiotherapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radiotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiotherapy companies profiled in this report include-

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

Radiotherapy by Segment

The study includes a forecast for the global radiotherapy market by type, application, end use, and region

Radiotherapy Market by Type [Analysis by Value from 2019 to 2031]:

• External Beam Radiation Therapy
• Internal Radiation Therapy
• Systemic Radiation Therapy

Radiotherapy Market by Application [Analysis by Value from 2019 to 2031]:

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

Radiotherapy Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Independent Radiotherapy Centers
• Others

Radiotherapy Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Radiotherapy Market

Here's the revised content without single line spaces between sentences, except for headings:

The radiotherapy market is growing at a rapid pace in all parts of the world owing to technological developments, the surge in the number of cancer patients, and the improvement in the status of healthcare services. With the growing recognition of the need for better healthcare, nations are now embracing new methods of radiotherapy and increasing the reach of these services. This growth in demand is additionally attributed to the incorporation of artificial intelligence and precision medicine into the practice of radiotherapy, which increases its effectiveness and safety.

• United States: Among some of the more recent changes in the radiotherapy industry in the United States is the quick adoption of advanced technologies, including proton therapy and SBRT. These modes allow for very precise delivery of radiation to the tumor with minimal damage to the surrounding healthy tissues. Further, the use of artificial intelligence in the treatment planning and delivery mechanisms has boosted the efficiency of radiotherapy, generating commendable results in patients. Finally, the US market is also committing itself to further investments that widen the scope of provision of radiotherapy services, for example, in terms of geography to include rural and clinically underserved regions, in both government and private initiatives.
• China: The radiotherapy market in China is also growing rapidly due to increasing cases of cancer, as well as considerable governmental investments in the healthcare system. Recent developments include improved control of x-ray treatment, where IMRT and IGRT techniques are extensively utilized. Besides, there is considerable activity in the form of building more cancer treatment centers with the best available radiotherapy equipment in China. Collaborations between Chinese institutes and foreign healthcare corporations will also help in the transfer of newer radiotherapy methods and technologies back to China so that it can provide more advanced cancer therapy.
• Germany: * Within the German market of radiotherapy, one has to admit that the country's healthcare is gradually leaning towards models of precision medicine, as well as models that advocate for personalized treatment in generic radiotherapy. Trends such as the growing popularity of using molecular imaging techniques together with radiotherapy to target tumor cells while sparing normal tissues are also underway. Germany is involved in examining strategies that combine radiotherapy with immunotherapy, thereby widening the possibilities for the immune response to tumors. Additionally, the country is working on eliminating geographic barriers for radiotherapy services by increasing the number of specialized centers and adopting state-of-the-art radiotherapy equipment.
• India: There has been significant development in the radiotherapy market in India due to increased awareness, government participation, and public-private partnerships in the cancer treatment sector. This development has led to more complex models evolving in payment structures, which intensify the introduction of advanced radiotherapy methods in cancer hospitals, such as stereotactic radiosurgery (SRS) or brachytherapy. There is also an increased focus on training, education, and orientation of personnel so that professionals can utilize modern radiotherapy technologies. Additionally, there is geographical imbalance in radiotherapy availability. New centers are being created in underserved areas to reduce disparities in cancer treatment across the country.
• Japan: The Japanese radiotherapy market is on an upward trajectory due to the incorporation of newer treatment techniques, including drug delivery using protons and heavy ions for distant and difficult-to-operate tumors. Recent developments also include the use of AI and machine learning in treatment planning, wherein the targeting dose is further improved. Efforts are being made to develop the radiotherapy infrastructure in Japan, with new cancer treatment facilities being built in response to the rising demand for modern cancer treatment services. In addition, there is a greater focus on research and development in the area of radiotherapy, with studies currently being undertaken to combine conventional forms of treatment with others, such as immunotherapy.

Features of the Global Radiotherapy Market

Market Size Estimates: Radiotherapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Radiotherapy market size by type, application, and region in terms of value ($B).

Regional Analysis: Radiotherapy Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the radiotherapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiotherapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the radiotherapy market by type (external beam radiation therapy, internal radiation therapy, and systemic radiation therapy), application (prostate cancer, breast cancer, lung cancer, colorectal cancer, cervical cancer, and others), end use (hospitals, independent radiotherapy centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radiotherapy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Radiotherapy Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Radiotherapy Market by Type
  • 3.3.1: External Beam Radiation Therapy
  • 3.3.2: Internal Radiation Therapy
  • 3.3.3: Systemic Radiation Therapy
• 3.4: Global Radiotherapy Market by Application
  • 3.4.1: Prostate Cancer
  • 3.4.2: Breast Cancer
  • 3.4.3: Lung Cancer
  • 3.4.4: Colorectal Cancer
  • 3.4.5: Cervical Cancer
  • 3.4.6: Others
• 3.5: Global Radiotherapy Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Independent Radiotherapy Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Radiotherapy Market by Region
• 4.2: North American Radiotherapy Market
  • 4.2.1: North American Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.2.2: North American Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.3: European Radiotherapy Market
  • 4.3.1: European Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.3.2: European Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.4: APAC Radiotherapy Market
  • 4.4.1: APAC Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.4.2: APAC Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.5: ROW Radiotherapy Market
  • 4.5.1: ROW Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.5.2: ROW Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Radiotherapy Market by Type
  • 6.1.2: Growth Opportunities for the Global Radiotherapy Market by Application
  • 6.1.3: Growth Opportunities for the Global Radiotherapy Market by End Use
  • 6.1.4: Growth Opportunities for the Global Radiotherapy Market by Region
• 6.2: Emerging Trends in the Global Radiotherapy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Radiotherapy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radiotherapy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ion Beam Applications
• 7.2: Elekta
• 7.3: Accuray Incorporated
• 7.4: Isoray
• 7.5: Becton
• 7.6: Dickinson and Company
• 7.7: Siemens Healthineers
• 7.8: ICAD
• 7.9: Nordion
• 7.10: MEVION MEDICAL SYSTEMS